A detailed history of Ensign Peak Advisors, Inc transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 38,974 shares of SRRK stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,974
Previous 38,974 -0.0%
Holding current value
$1.17 Million
Previous $324,000 3.7%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$13.2 - $17.76 $25,951 - $34,916
-1,966 Reduced 4.8%
38,974 $692,000
Q3 2023

Nov 13, 2023

BUY
$6.02 - $7.76 $25,284 - $32,592
4,200 Added 11.43%
40,940 $290,000
Q2 2023

Aug 14, 2023

BUY
$5.79 - $9.11 $34,161 - $53,749
5,900 Added 19.13%
36,740 $277,000
Q1 2023

May 15, 2023

BUY
$7.36 - $12.72 $47,104 - $81,408
6,400 Added 26.19%
30,840 $246,000
Q4 2022

Feb 13, 2023

BUY
$7.02 - $9.76 $43,875 - $61,000
6,250 Added 34.36%
24,440 $221,000
Q3 2022

Nov 14, 2022

SELL
$5.33 - $11.3 $34,964 - $74,128
-6,560 Reduced 26.51%
18,190 $126,000
Q2 2022

Aug 12, 2022

BUY
$4.66 - $13.96 $55,966 - $167,659
12,010 Added 94.27%
24,750 $136,000
Q4 2021

Feb 11, 2022

BUY
$24.14 - $35.18 $307,543 - $448,193
12,740 New
12,740 $316,000
Q3 2021

Nov 12, 2021

SELL
$27.38 - $42.21 $387,728 - $597,735
-14,161 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$45.96 - $68.02 $371,448 - $549,737
8,082 Added 132.95%
14,161 $717,000
Q4 2020

Feb 12, 2021

BUY
$13.72 - $51.57 $83,403 - $313,494
6,079 New
6,079 $295,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $1.55B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.